Louisiana 2025 Regular Session

Louisiana House Bill HB176

Introduced
3/31/25  
Refer
3/31/25  
Refer
4/14/25  
Report Pass
4/29/25  
Engrossed
5/7/25  
Refer
5/8/25  
Report Pass
5/20/25  
Enrolled
6/2/25  
Chaptered
6/8/25  

Caption

Provides relative to regulation of certain hallucinogenic chemicals (EN SEE FISC NOTE GF EX)

Impact

The enactment of HB 176 will introduce stringent criminal penalties for individuals involved with these prohibited substances. Under this law, individuals found guilty of illegal production or distribution face severe consequences, including imprisonment for up to ten years and significant fines. Additionally, the law will penalize possession of these hallucinogenic chemicals, marking a considerable shift in state law towards stricter regulation of substances that were previously less defined in legal terms.

Summary

House Bill 176 aims to regulate certain hallucinogenic chemicals by prohibiting their production, manufacturing, distribution, or possession within the state of Louisiana. This legislation focuses on specific substances, notably beta-phenyl-GABA, muscimol, and ibotenic acid, which have been identified due to their psychoactive effects. The introduction of this bill comes in response to growing concerns regarding the safety and legality of these substances, signaling a proactive legislative effort to control their availability and mitigate associated health risks.

Sentiment

The sentiment surrounding HB 176 is largely supportive among legislators who prioritize public health and safety. Proponents argue that the bill is necessary for protecting the community against the potential harms associated with these substances. Conversely, there may be concerns from civil liberties advocates regarding the implications of increased criminalization and whether such measures could exacerbate issues related to drug enforcement and prison overcrowding.

Contention

Key points of contention include the balance between enforcing public safety and ensuring individual rights. Critics of the bill may argue that focusing on punitive measures could detract from more effective public health approaches, such as education and treatment for substance use disorders. The bill also raises important questions about the definitions of 'hallucinogenic chemicals' and the potential for overreach in regulating substances that could be considered benign or used legitimately.

Companion Bills

No companion bills found.

Previously Filed As

LA HB645

Creates the crime of unlawful production, manufacturing, distribution, or possession of Xylazine (EN SEE FISC NOTE GF EX See Note)

LA HB735

Provides relative to penalties for distribution or possession with intent to distribute certain controlled dangerous substances (OR SEE FISC NOTE GF EX)

LA HB720

Provides relative to distribution of fentanyl under certain circumstances (EN SEE FISC NOTE GF EX See Note)

LA HB978

Provides relative to the regulation of cannabis (EG SEE FISC NOTE SG RV)

LA HB90

Provides relative to penalties for distribution or possession with intent to distribute fentanyl or carfentanil (EN INCREASE GF EX See Note)

LA HB707

Provides relative to the regulation of cannabis (EG INCREASE SG RV See Note)

LA HB17

Provides relative to the regulation of cannabis (OR INCREASE SG EX See Note)

LA HB8

Provides relative to distribution of fentanyl under certain circumstances (Item #24) (EN INCREASE GF EX See Note)

LA HB54

Provides relative to the regulation of cannabis (OR INCREASE SG RV See Note)

LA SB219

Provides relative to industrial hemp. (gov sig) (EG1 INCREASE GF EX See Note)

Similar Bills

No similar bills found.